Spondyloepiphyseal or spondyloepimetaphyseal dysplasias (Q49817): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Displasias espondiloepifisárias (SED) são um grupo heterogêneo de condrodisplasias congênitas que afetam especificamente epífises e vértebras. A sua forma mais frequente é caracterizada pelo pequeno tamanho neonatal de vértebras ovoides e crescimento geral tardio dos ossos, mais acentuado nas cabeças femorais, com um limite metafisário ligeiramente irregular. Outras formas clínicas foram descritas, algumas das quais eram dominantes e mais ou menos graves com lesões metafisárias, enquanto outras eram recessivas e incluíam síndrome nefrótica, linfopenia e transtornos imunológicos (displasia óssea imune). | |||||||||||||||
| description / en | description / en | ||||||||||||||
Spondyloepiphyseal dysplasias (SED) are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. Their most frequent form is characterised by small neonatal size of ovid vertebrae and overall late growth of bones, more marked in the femoral heads, with a slightly irregular metaphyseal limit. Other clinical forms have been described, some of which were dominant and more or less severe with metaphyseal lesions, while others were recessive and included nephrotic syndrome, lymphopenia, and immune disorders (immune bone dysplasia). | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1977414063 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:LD24.3 | |||||||||||||||
| Property / CURIE: CID11:LD24.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-LD24.3 | |||||||||||||||
| Property / Canary Token: dki-india-LD24.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: XVII / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 20:18, 13 August 2026
Spondyloepiphyseal dysplasias (SED) are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. Their most frequent form is characterised by small neonatal size of ovid vertebrae and overall late growth of bones, more marked in the femoral heads, with a slightly irregular metaphyseal limit. Other clinical forms have been described, some of which were dominant and more or less severe with metaphyseal lesions, while others were recessive and included nephrotic syndrome, lymphopenia, and immune disorders (immune bone dysplasia).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | LD24.3 |
||
| English | Spondyloepiphyseal or spondyloepimetaphyseal dysplasias |
Spondyloepiphyseal dysplasias (SED) are a heterogeneous group of congenital chondrodysplasias that specifically affect epiphyses and vertebrae. Their most frequent form is characterised by small neonatal size of ovid vertebrae and overall late growth of bones, more marked in the femoral heads, with a slightly irregular metaphyseal limit. Other clinical forms have been described, some of which were dominant and more or less severe with metaphyseal lesions, while others were recessive and included nephrotic syndrome, lymphopenia, and immune disorders (immune bone dysplasia). |
Statements
CID11:LD24.3
0 references
dki-india-LD24.3
0 references
Concluído
0 references
13 August 2026
0 references
